Japanese Journal of Clinical Oncology Advance Access published online on July 22, 2006
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyl063
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
* To whom correspondence should be addressed. Background: We investigated whether thymidine phosphorylase (TP) protein level in renal cell carcinoma (RCC) correlates with clinicopathological characteristics and clinical outcomes. Methods: TP protein level was measured in 116 RCC specimens and in 90 non-neoplastic kidney tissues using a sandwich-type enzyme-linked immunosolvent assay. Results: The median TP protein level in RCC tissues was 9.76-fold (range, 3.2-933.9) higher than those in non-neoplastic kidney tissues (P < 0.0001). TP protein level was correlated with T classification, histological grade and mode of infiltration. TP as a prognostic variable was studied using a logistic regression model. TP at higher levels (128 U/mg protein or greater) would play a role as an independent prognostic factor (odds ratio, 13.73; 95% confidence interval, 2.09-90.41; P = 0.0064). Conclusion: TP at high levels can be regarded as an unfavorable independent prognostic factor. These results may pave a way for a novel approach to effective treatment of RCC.
Received April 3, 2006
Accepted May 21, 2006
Original Article
High Levels of Thymidine Phosphorylase as an Independent Prognostic Factor in Renal Cell Carcinoma
Tatsuya Takayama 1 *, Soichi Mugiya 1, Takayuki Sugiyama 1, Takahiro Aoki 1, Hiroshi Furuse 1, Hongming Liu 1, Yasuhiro Hirano 2, Fumitake Kai 3, Tomomi Ushiyama 1, and Seiichiro Ozono 1
2 Fujieda Municipal General Hospital, Fujieda, Shizuoka, Japan
3 Haibara General Hospital, Makinohara, Shizuoka, Japan
Tatsuya Takayama, E-mail: takayama{at}hama-med.ac.jp
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?